BSE Live
Apr 08, 16:00Prev. Close
34.62
Open Price
36.35
Bid Price (Qty.)
35.31 (97)
Offer Price (Qty.)
35.39 (436)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 0.32 | 0.04 | -0.08 | |
| Diluted EPS (Rs.) | 0.32 | 0.04 | -0.08 | |
| Cash EPS (Rs.) | 0.73 | 0.51 | 0.40 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -0.18 | -0.50 | -0.54 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -0.18 | -0.50 | -0.54 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 9.61 | 8.17 | 4.25 | |
| PBDIT/Share (Rs.) | 1.20 | 0.60 | 0.64 | |
| PBIT/Share (Rs.) | 0.79 | 0.12 | 0.16 | |
| PBT/Share (Rs.) | 0.32 | 0.05 | -0.07 | |
| Net Profit/Share (Rs.) | 0.32 | 0.04 | -0.08 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 12.51 | 7.30 | 15.04 | |
| PBIT Margin (%) | 8.26 | 1.51 | 3.69 | |
| PBT Margin (%) | 3.33 | 0.60 | -1.74 | |
| Net Profit Margin (%) | 3.33 | 0.47 | -1.82 | |
| Return on Networth / Equity (%) | -178.52 | -7.80 | 0.00 | |
| Return on Capital Employed (%) | 4.31 | 0.50 | 1.87 | |
| Return on Assets (%) | 3.12 | 0.32 | -0.61 | |
| Total Debt/Equity (X) | -36.19 | -14.14 | -14.51 | |
| Asset Turnover Ratio (%) | 93.68 | 68.15 | 33.67 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 2.60 | 2.02 | 2.09 | |
| Quick Ratio (X) | 2.51 | 1.98 | 1.87 | |
| Inventory Turnover Ratio (X) | 37.07 | 51.30 | 4.43 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 6.12 | 6.65 | 7.12 | |
| EV/Net Operating Revenue (X) | 0.71 | 0.91 | 1.86 | |
| EV/EBITDA (X) | 5.66 | 12.41 | 12.40 | |
| MarketCap/Net Operating Revenue (X) | 0.05 | 0.06 | 0.12 | |
| Retention Ratios (%) | 100.00 | 100.00 | 0.00 | |
| Price/BV (X) | -2.79 | -1.00 | -0.93 | |
| Price/Net Operating Revenue | 0.05 | 0.06 | 0.12 | |
| Earnings Yield | 0.64 | 0.08 | -0.15 |
10.02.2026
Shukra Pharma Consolidated December 2025 Net Sales at Rs 39.13 crore, up 269.74% Y-o-Y
09.02.2026
Shukra Pharma Standalone December 2025 Net Sales at Rs 39.13 crore, up 269.74% Y-o-Y
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth